ImmunityBio, Inc.
$7.87
-0.08 (-1.01%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +10.1%
- 3 Months
- +8.9%
- YTD
- +297.5%
- 1 Year
- +236.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 104.4%
- Largest decline max drawdown, since Aug 2025
- -42.3%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.65
Own IBRX?
See how IBRX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.